Gómez-Acebo & Pombo has advised the issuer in the IPO process of Labiana Health. The company will be the first Spanish veterinary company to enter the market and expects to be listed on BME Growth in mid-June through a capital increase.
Labiana is an animal and human health platform, aimed at raising capital to accelerate its organic and inorganic growth. The company already has a firm commitment from Inveready, which, through a convertible bond, will invest up to 4 million subject to completing the IPO. Labiana's roadmap envisages issuing new shares equivalent to 30% or 40% of its share capital to raise a significant amount of money that will be used to boost the growth that the group has been experiencing in recent years.
Augusto Piñel, Jacobo Palanca, Emiliano Moreno and Irene Carreño Uría, Mercantil partner and associates, have advised on the transaction.